Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $114000.0.

  • Apyx Medical's Asset Writedowns and Impairment rose 3255.81% to $114000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $536000.0, marking a year-over-year increase of 2181.82%. This contributed to the annual value of $396000.0 for FY2024, which is 2428.3% down from last year.
  • According to the latest figures from Q3 2025, Apyx Medical's Asset Writedowns and Impairment is $114000.0, which was up 3255.81% from $144000.0 recorded in Q2 2025.
  • Apyx Medical's 5-year Asset Writedowns and Impairment high stood at $294000.0 for Q4 2023, and its period low was -$142000.0 during Q1 2023.
  • Its 5-year average for Asset Writedowns and Impairment is $86736.8, with a median of $71000.0 in 2021.
  • Data for Apyx Medical's Asset Writedowns and Impairment shows a peak YoY increase of 1750000.0% (in 2023) and a maximum YoY decrease of 20142.86% (in 2023) over the last 5 years.
  • Over the past 5 years, Apyx Medical's Asset Writedowns and Impairment (Quarter) stood at $71000.0 in 2021, then plummeted by 54.93% to $32000.0 in 2022, then skyrocketed by 818.75% to $294000.0 in 2023, then decreased by 14.97% to $250000.0 in 2024, then plummeted by 54.4% to $114000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $114000.0 for Q3 2025, versus $144000.0 for Q2 2025 and $28000.0 for Q1 2025.